The long-term effect of cupping therapy is not known, but use of cupping is generally safe based on long term clinical use and reports from the reviewed clinical studies.
On the other hand, despite great efforts have been currently made to use the most accurate and up-to-date data sources to provide a realistic simulation of T2DM in Argentina, the model has a limitation shared by most modeling studies, namely, the uncertainty around projecting long-term outcomes based on clinical input data from a short-term study.
This evidence is based on clinical trials of the short-term effect of exercise programs in patients with chronic diseases, who are often institutionalized,[ 8, 9] and in cross-sectional studies, which have limited capacity to establish causal relations because HRQoL itself may influence the ability to do physical activity [ 10- 16].
Based on clinical findings they further subdivide these terms into acute purulent, subacute purulent and chronic purulent osteitis [1, 2].
The current health-economic analysis indicated that based on clinical findings for PROactive and long-term projections with a modified version of the CORE Diabetes Model, treatment with pioglitazone was associated with improvements in life expectancy and quality-adjusted life expectancy compared to placebo.
1 Long-term exposure studies based on clinical outcomes presumably integrate atherosclerosis progression and acute triggering effects, and thus have greater effect sizes than short-term exposure studies.
Concurrently, following the reports of long-term clinical manifestations of Ross River virus disease, two prospective longitudinal studies were conducted, one of them based on clinical review [24], [25].
Clinical long-term outcomes were based on clinical assessment of bilateral hip motions for subjects operated unilaterally and without signs of an asymptomatic slip at follow-up (n = 31).
Samyshkin et al 66 used the IMS Core Diabetes Model costs to project long-term cost utility based on clinical outcomes and direct medical costs when comparing treating T2DM patients with exenatide ER once weekly or insulin glargine from a US payer prospective.
Prediction should be based on clinical global judgment, and instruments designed to predict short-term aggression in psychiatric inpatients.
